Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Sales 36,500 26,820 14,240 0 203,200
Sales Growth +36.09% +88.34% unch -100.00% +72.33%
Net Income 673,730 -352,090 -231,800 1,604,720 -327,370
Net Income Growth +291.35% -51.89% -114.44% +590.19% +20.44%

Balance Sheet

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Total Assets 1,663,200 937,120 1,238,720 1,437,740 852,950
Total Assets Growth +77.48% -24.35% -13.84% +68.56% -4.24%
Total Liabilities 122,240 126,100 137,900 145,760 453,450
Total Liabilities Growth -3.06% -8.56% -5.39% -67.86% +81.23%

Cash Flow

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Operating Cash Flow -389,840 -296,060 -309,480 -407,320 -290,760
Operating Cash Flow Growth -31.68% +4.34% +24.02% -40.09% +21.55%
Net Cash Flow -11,960 -51,050 -63,870 75,690 46,510
Change in Net Cash Flow +76.57% +20.07% -184.38% +62.74% +345.93%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot